NCT04713904View on ClinicalTrials.gov

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 16, 2021

Primary Completion Date

January 16, 2021

Study Completion Date

February 2, 2021

Conditions
Bioequivalence
Interventions
DRUG

Clormadinone 2 mg and Ethinyl estradiol 0.02 mg Test Product Coated Tablets

Investigational Medicinal Product

DRUG

Clormadinone 2 mg and Ethinyl estradiol 0.02 mg Reference Product Coated Tablets

Evafem 20 (Trademark)

Trial Locations (1)

7510491

Innolab, Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT04713904 - Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter